Loring Wolcott & Coolidge Fiduciary Advisors LLP Bluebird Bio, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$10.9 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $6,765 - $8,283	375 New	375 $12,000
Q1 2021 Apr 14, 2021	SELL	$16.59 - $33.89 $6,221 - $12,708	-375 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$75.84 - $105.21 $28,440 - $39,453	375 New	375 $47,000

Others Institutions Holding BLUE

# of Institutions

Shares Held

42.6M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$93.3 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$28.2 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$23.2 Million
0.0% of portfolio
Avidity Partners Management LP Dallas, TX

1.63M
Shares

$9.85 Million
0.05% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.61M
Shares

$9.72 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account